3,4-dihydroxyphenylacetic acid has been researched along with riluzole in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Blin, O; Dusticier, N; Nieoullon, A; Samuel, D | 1 |
| D'Angio, M; Scatton, B; Serrano, A | 1 |
| Boireau, A; Bordier, F; Doble, A; Dubédat, P | 1 |
| Boireau, A; Bordier, F; Doble, A; Dubédat, P; Durand, G; Meunier, M; Miquet, JM; Peny, C | 1 |
| Boireau, A; Doble, A; Dubédat, P; Meunier, M; Miquet, JM | 1 |
| Araki, T; Ido, T; Imai, Y; Itoyama, Y; Kumagai, T; Matsubara, M | 1 |
| Araki, T; Imai, Y; Matsubara, M; Muramatsu, Y; Tanaka, K | 1 |
| Araki, T; Imai, Y; Itoyama, Y; Kato, H; Kumagai, T; Matsubara, M; Tanaka, K | 1 |
10 other study(ies) available for 3,4-dihydroxyphenylacetic acid and riluzole
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Effects of riluzole (2-amino-6-trifluoromethoxy benzothiazole) on striatal neurochemical markers in the rat, with special reference to the dopamine, choline, GABA and glutamate synaptosomal high affinity uptake systems.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aspartic Acid; Biomarkers; Choline; Corpus Striatum; Culture Media; Dopamine; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Hydroxyindoleacetic Acid; Neurotransmitter Uptake Inhibitors; Rats; Rats, Wistar; Riluzole; Serotonin; Synaptic Transmission; Synaptosomes; Thiazoles; Tritium | 1992 |
NMDA antagonists block restraint-induced increase in extracellular DOPAC in rat nucleus accumbens.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Antagonists; Animals; Aspartic Acid; Carbolines; Convulsants; Diazepam; Male; N-Methylaspartate; Nucleus Accumbens; Phenylacetates; Piperazines; Piperidines; Rats; Rats, Inbred Strains; Restraint, Physical; Riluzole; Septal Nuclei; Thiazoles | 1989 |
Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Dizocilpine Maleate; Dopamine; Dopamine Agents; Excitatory Amino Acid Antagonists; Glutamic Acid; Lamotrigine; Male; Methamphetamine; Mice; Mice, Inbred Strains; Neostriatum; Neurons; Riluzole; Sodium Channels; Synaptic Transmission; Thiazoles; Triazines | 1995 |
Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Riluzole; Thiazoles | 1994 |
Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Excitatory Amino Acid Antagonists; Extracellular Space; Homovanillic Acid; Male; Parkinson Disease, Secondary; Rats; Riluzole; Thiazoles | 1994 |
Protective effect of riluzole on MPTP-induced depletion of dopamine and its metabolite content in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Pargyline; Receptors, N-Methyl-D-Aspartate; Riluzole; Sodium Channels; Time Factors | 2000 |
Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Astrocytes; Dopamine; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Excitatory Amino Acid Antagonists; Glial Fibrillary Acidic Protein; Glutamic Acid; Homovanillic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Neostriatum; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Riluzole; Substantia Nigra; Tyrosine 3-Monooxygenase | 2001 |
Neuroprotective effect of riluzole in MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Glutamic Acid; Homovanillic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neostriatum; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Riluzole; Substantia Nigra; Synaptic Transmission; Tyrosine 3-Monooxygenase | 2001 |